On October 8 and 9, 2026, Cellura will attend Innovative Therapies Days 2026 at the Kursaal in Besançon, France.
Established as a European forum dedicated to advanced therapies, the event brings together academic researchers, clinicians, biotech and pharmaceutical companies, industrial partners and innovation stakeholders involved in transforming emerging therapeutic concepts into solutions that can ultimately reach patients.
For Cellura, Innovative Therapies Days represents an opportunity to engage with a community addressing one of the central challenges in advanced therapies today: how to translate increasingly sophisticated cellular technologies from scientific innovation toward controlled, reproducible and scalable applications.
From Scientific Discovery to Advanced Therapy Development
The development of advanced therapies extends far beyond demonstrating the biological potential of a new therapeutic approach.
Moving from discovery toward clinical application requires scientific innovation to be accompanied by progress in manufacturing, process control, automation, regulation and industrialization. Innovative Therapies Days has been designed precisely around this translational challenge, bringing together scientific, technological, regulatory and operational perspectives.
The 2026 program reflects the diversity of this transition. Discussions will span next-generation CAR-T and TCR strategies, cell therapy manufacturing, regenerative medicine, pluripotent stem cells, extracellular vesicles and emerging enabling technologies.
Rather than considering these areas independently, the event creates a common space to examine how advanced biological concepts can progress toward therapies that are reproducible, manufacturable and accessible.
Cell Manufacturing at the Center of Translation
A particularly relevant theme for Cellura will be the transition toward more scalable cell manufacturing.
One of the major sessions, Can Regenerative Medicine Become Industrial Reality?, will focus specifically on stem cell manufacturing, automation and the path to industrial scale. The program includes discussions on pluripotent stem cell manufacturing, clinical translation and the use of digital technologies in cell therapy production.
This reflects a broader evolution within the field. As cell therapies progress toward clinical and industrial applications, manufacturing strategies must support increasingly complex biological products while improving consistency, reproducibility and scalability.
Cell culture therefore becomes part of the translational challenge itself. Expanding sensitive cell populations while preserving the characteristics required for their intended application is essential when moving from experimental workflows toward more standardized production environments.
Beyond Cells: Extracellular Vesicles and Emerging Technologies
The 2026 program also looks beyond conventional cell transplantation. A dedicated session entitled What Comes After Cells? will explore extracellular vesicles, cell-free therapies and enabling technologies, including the clinical potential of MSC-derived extracellular vesicles, EV engineering for RNA delivery and the regulatory landscape surrounding these emerging therapeutic approaches.
This expansion toward cell-derived products illustrates how rapidly the advanced therapy field is diversifying.
At the same time, emerging technologies are becoming increasingly integrated into therapeutic development. The program will address areas including AI-supported cell therapy manufacturing, automated cell culture, real-time quality control and microtechnologies for advanced therapies.
Together, these topics reinforce a central message: the future of advanced therapies will depend not only on new biological discoveries, but also on the technologies and processes capable of translating them into reliable therapeutic products.
Cellura’s Perspective on Advanced Cell Culture
These challenges closely align with Cellura’s work in advanced cell culture. Through the development of the SoftXS™, Cellura is exploring controlled and gentle culture approaches for sensitive biological systems, with applications spanning immune cells, pluripotent stem cells and advanced 3D cellular models.
Innovative Therapies Days provides a particularly relevant environment to discuss how cell culture technologies can accompany the transition from research toward more reproducible and scalable workflows.
The objective is not simply to increase cell numbers. It is to consider how cell biology, culture conditions and process development can evolve together as advanced therapies move toward increasingly demanding translational and manufacturing contexts.
Meet Cellura in Besançon
Cellura’s participation in Innovative Therapies Days 2026 will provide an opportunity to meet researchers, clinicians, cell therapy developers, process development teams and industrial partners working across the advanced therapy ecosystem.
The team looks forward to discussing current challenges in advanced cell culture and learning more about emerging projects involving immune cells, stem cells, pluripotent stem cells and other sensitive cellular models.
These discussions will also provide opportunities to explore potential scientific and technological collaborations around the development of more controlled and scalable cell culture workflows.
Advancing the Translation of Innovative Therapies
The development of advanced therapies increasingly depends on the ability to connect biological innovation with technological and manufacturing innovation.
From engineered immune cells and regenerative medicine to extracellular vesicles and emerging manufacturing technologies, Innovative Therapies Days 2026 reflects a field moving toward increasingly sophisticated therapeutic strategies and more mature translational pathways.
By attending Innovative Therapies Days 2026, Cellura continues its engagement with the advanced therapy community and its commitment to supporting the evolution of cell culture technologies for research, translation and scalable applications.
We look forward to meeting the community in Besançon on October 8 and 9, 2026.
About the Event
More information about Innovative Therapies Days 2026 is available on the official website: https://www.innovativetherapiesdays.com/
For further information or to arrange a meeting with the Cellura team during the event:
Email: contact@cellura.io
